---
title: "Machine learning models predict parental HPV vaccine hesitancy in Cameroon: development and intern"
id: "medrxiv-16-predicting-parental-human-papillomavirus-vaccine-hesitancy-development-and"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-16-predicting-parental-human-papillomavirus-vaccine-hesitancy-development-and"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.18.26363393v1?rss=1"
published_at: "2026-09-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Machine learning models predict parental HPV vaccine hesitancy in Cameroon: development and intern
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-16-predicting-parental-human-papillomavirus-vaccine-hesitancy-development-and
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.18.26363393v1?rss=1)
- **Published At:** 2026-09-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Study developed and internally validated machine learning and regression models to predict parental **HPV vaccine hesitancy** using a cross-sectional survey of 1,156 parents of children aged 9–18 in the Buea Health District, Cameroon. - Outcome (hesitancy) was derived from self-reported vaccination status and vaccination intention. - Twenty-six predictor groups were screened; group LASSO retained 17 predictor groups for **logistic regression**, while tree-based models used all 26 groups. - Data were split 80/20 into a training set (n=925) and test set (n=231); models tuned with repeated cross-validation and thresholds set by Youden’s J statistic. - Three algorithms were developed and compared: **logistic regression**, **random forest**, and **XGBoost**; model predictions were interpreted using **SHAP** values. - Discrimination across models was comparable with AUC-ROC ranging from 0.841 to 0.870; **XGBoost** had the highest AUC (0.870) and logistic regression AUC was 0.869 (DeLong p=0.965 comparing the two). - Logistic regression achieved the highest sensitivity (73.1%), the highest F1-score (74.9%), and the lowest Brier score (0.1435) on the held-out test set. - Calibration slopes for all models exceeded 1 (range 1.12–1.46), indicating calibration characteristics reported in the source. - Dominant predictors identified were **insufficient vaccine information**, **perceived vaccine unsafety**, and **distrust in the Ministry of Health**; sociodemographic disadvantage was less predictive than information access and institutional trust. - Authors conclude algorithmic complexity did not outperform standard regression and recommend trust-building engagement over broad demographic campaigns for reducing hesitancy. - Ethical approval was obtained from the University of Buea Ethics Committee/IRB (Ethics Registration number 2023/1949-02).
## Clinical Analysis & Structured Key Points
Predicting parental Human papillomavirus vaccine hesitancy: development and internal validation of machine learning models | medRxiv Skip to main content Predicting parental Human papillomavirus vaccine hesitancy: development and internal validation of machine learning models Israel Oluwamayomikun Alabi , Daniel Biftu Bekalo , Christiana Kartsonaki , View ORCID Profile Valirie Ndip Agbor doi: https://doi.org/10.64898/2026.09.18.26363393 Israel Oluwamayomikun Alabi 1 African Institute for Mathematical Sciences (AIMS) Cameroon; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Daniel Biftu Bekalo 2 Centre for Artificial Intelligence & Multidisciplinary Innovation Studies, Department of Auditing, College of Accounting Sciences, University of South Africa, Pretoria, South Africa; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Christiana Kartsonaki 3 Nuffield Department of Population Health, University of Oxford, United Kingdom; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Valirie Ndip Agbor 4 Global Health Trials Unit, Liverpool School of Tropical Medicine, United Kingdom Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Valirie Ndip Agbor For correspondence: nvagbor{at}gmail.com Abstract Info/History Metrics Data/Code Preview PDF Abstract Objectives: Cervical cancer is Cameroon's second most common cancer among women. However, high parental Human papillomavirus (HPV) vaccine hesitancy impedes elimination, and no validated predictive tool exists. This study aimed to develop and internally validate machine learning models predicting parental HPV vaccine hesitancy in the Buea Health District and identify key predictors. Methods: This secondary analysis used cross-sectional survey data from 1,156 parents of children aged 9-18 years. Hesitancy was derived from self-reported vaccination status and intention. Twenty-six predictor groups were screened via group LASSO (17 retained for logistic regression; all 26 for tree-based models). Data were split 80/20 into training (n=925) and test (n=231) sets. Logistic regression, random forest, and XGBoost were tuned via repeated cross-validation while thresholds were set by Youden's J statistic. Discrimination, calibration, and Brier score were assessed on the test set. Predictions were interpreted using SHAP. Results: All models showed comparable discrimination (AUC-ROC 0.841-0.870). XGBoost had the highest AUC (0.870, vs 0.869 for logistic regression, DeLong p=0.965); logistic regression had the highest sensitivity (73.1%), F1-score (74.9%), and lowest Brier score (0.1435). Calibration slopes exceeded 1 (1.12-1.46) across models. Insufficient vaccine information, perceived vaccine unsafety, and distrust in the Ministry of Health were the dominant predictors. Discussion: The three models achieved comparable, clinically meaningful discrimination, and algorithmic complexity did not improve prediction over standard regression. Hesitancy was more strongly predicted by information access and institutional trust than sociodemographic disadvantage. Conclusion: These findings support trust-building engagement over broad demographic campaigns. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study was approved by the Ethics Committee and Institutional Review Board of the University of Buea (Ethics Registration number 2023/1949-02). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present study are available upon reasonable request to the authors Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Next Posted September 20, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Predicting parental Human papillomavirus vaccine hesitancy: development and internal validation of machine learning models Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Predicting parental Human papillomavirus vaccine hesitancy: development and internal validation of machine learning models Israel Oluwamayomikun Alabi , Daniel Biftu Bekalo , Christiana Kartsonaki , Valirie Ndip Agbor medRxiv 2026.09.18.26363393; doi: https://doi.org/10.64898/2026.09.18.26363393 Share This Article: Copy Citation Tools Predicting parental Human papillomavirus vaccine hesitancy: development and internal validation of machine learning models Israel Oluwamayomikun Alabi , Daniel Biftu Bekalo , Christiana Kartsonaki , Valirie Ndip Agbor medRxiv 2026.09.18.26363393; doi: https://doi.org/10.64898/2026.09.18.26363393 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Infectious Diseases (except HIV/AIDS) Subject Areas All Articles Addiction Medicine (619) Allergy and Immunology (903) Anesthesia (334) Cardiovascular Medicine (4828) Dentistry and Oral Medicine (479) Dermatology (419) Emergency Medicine (651) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1633) Epidemiology (15974) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7065) Geriatric Medicine (734) Health Economics (1066) Health Informatics (5060) Health Policy (1437) Health Systems and Quality Improvement (1775) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16307) Intensive Care and Critical Care Medicine (1174) Medical Education (671) Medical Ethics (155) Nephrology (727) Neurology (7291) Nursing (368) Nutrition (1084) Obstetrics and Gynecology (1243) Occupational and Environmental Health (1005) Oncology (3614) Ophthalmology (1055) Orthopedics (398) Otolaryngology (457) Pain Medicine (472) Palliative Medicine (139) Pathology (709) Pediatrics (1805) Pharmacology and Therapeutics (739) Primary Care Research (768) Psychiatry and Clinical Psychology (5919) Public and Global Health (9770) Radiology and Imaging (2432) Rehabilitation Medicine and Physical Therapy (1456) Respiratory Medicine (1250) Rheumatology (642) Sexual and Reproductive Health (773) Sports Medicine (579) Surgery (782) Toxicology (107) Transplantation (305) Urology (293)
## Related Clinical Research

- [Understanding Parasitic Identification in Delusional Parasitosis](https://medichelpline.com/clinical-feed/plos-one-21-bridging-perception-and-reality-parasitic-identification-in-delusional.md)
- [Microbiome Profiling Identifies Prognostic Heterogeneity in Staphylococcus aureus Pneumonia](https://medichelpline.com/clinical-feed/medrxiv-18-microbiome-profiling-reveals-prognostic-heterogeneity-in-staphylococcus-aureus.md)
- [Impact of mass oral cholera vaccination in Uvira, DRC: surveillance-based counterfactual analysis](https://medichelpline.com/clinical-feed/medrxiv-13-impact-of-mass-oral-cholera-vaccination-in-an-endemic-area-of-the-democratic.md)
- [Kennedy renews attacks on vaccines at Children’s Health Defense conference](https://medichelpline.com/clinical-feed/stat-news-1-kennedy-renews-attacks-on-vaccines-at-children-s-health-defense-conference.md)
- [Study says purer fentanyl won’t by itself explain U.S. overdose death decline](https://medichelpline.com/clinical-feed/stat-news-2-purer-fentanyl-won-t-solve-the-u-s-overdose-death-crisis-study-says.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.